Supernus Pharmaceuticals announced its participation in three prominent healthcare investor conferences scheduled for March 2026. The company's management team will present at the TD Cowen 46th Annual Health Care Conference on March 2, the Jefferies Biotech on the Beach Summit on March 10, and the Barclays 28th Annual Global Healthcare Conference on March 11.
The conference presentations will provide institutional investors and industry analysts with updates on the company's strategic initiatives and operational progress. Select presentations will be accessible via live webcast, allowing broader participation from the investment community and other stakeholders unable to attend in person.
These appearances represent standard investor relations activity for publicly traded pharmaceutical companies, enabling direct engagement with capital markets participants during a concentrated period of healthcare-focused conference activity.